![Page 1: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/1.jpg)
Neurocognitive Disorders of the DSM-5
Allyson Rosen, PhD, ABPP-Cn
Director of Dementia Education
Mental Illness Research, Education, and Clinical Center (MIRECC)
VA Palo Alto Health Care System
Clinical Associate Professor (Affiliated) Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
![Page 2: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/2.jpg)
Speakers
• Allyson Rosen • Ruth O’Hara • Maya Yutsis • Brian Yochim • Geoff Kerchner
![Page 3: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/3.jpg)
![Page 4: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/4.jpg)
Neurocognitive Disorders
• Delirium • Major and Mild Neurocognitive
Disorder (NCD)
![Page 5: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/5.jpg)
Neurocognitive Disorders (NCD)
• Primarily COGNITIVE disorders • Acquired and represent decline
(i.e. not developmental)
![Page 6: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/6.jpg)
Neurocognitive Disorders
• Primarily COGNITIVE disorders • Acquired and represent decline
(i.e. not developmental)
• Underlying brain pathology • For degenerative disorders monitor consensus
guidelines in addition to DSM 5
![Page 7: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/7.jpg)
Updates on Neurocognitive Disorders????
![Page 8: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/8.jpg)
Updates on Neurocognitive Disorders????
NO We can still be
Updates on Dementia
![Page 9: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/9.jpg)
Neurocognitive Disorders (NCD) vs.
Dementia
• Dementia typically refers to degenerative d/o in elderly
![Page 10: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/10.jpg)
Neurocognitive Disorders (NCD) vs.
Dementia
• Dementia typically refers to degenerative d/o in elderly
• DSM expands category to d/o of younger – E.g. HIV, traumatic brain injury
![Page 11: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/11.jpg)
Major and Mild Neurocognitive Disorders
(NCD)
![Page 12: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/12.jpg)
Major NCD
• Significant Cognitive Decline • Interfere with independence • Not due to delirium • Not due to other mental disorder
![Page 13: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/13.jpg)
Major NCD vs. Dementia
• Can be single domain – E.g. Amnestic – Exception: Major NCD due to
Alzheimer’s disease.
![Page 14: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/14.jpg)
Major NCD
• Significant Cognitive Decline • Interfere with independence • Not due to delirium • Not due to other mental disorder
![Page 15: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/15.jpg)
Mild NCD
• Moderate Cognitive Decline • NOT Interfere with independence • Not due to delirium • Not due to other mental disorder
![Page 16: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/16.jpg)
Mild NCD
• Like mild cognitive impairment • Previously:
Cognitive Disorder Not Otherwise Specified
![Page 17: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/17.jpg)
Major and Mild Neurocognitive Disorders
• Cognition: Psychometric Definition
![Page 18: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/18.jpg)
Mild vs Major NCD Cognitive Testing
• Mild: 1–2 standard deviation (SD) range (between the 3rd and 16th percentiles)
• Major: Below 2 SD or 3rd percentile
![Page 19: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/19.jpg)
Test Scores
![Page 20: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/20.jpg)
Test Scores
MILD
MAJOR
![Page 21: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/21.jpg)
Mild vs Major NCD Cognitive Testing
• Mild: 1–2 standard deviation (SD) range (between the 3rd and 16th percentiles)
• Major: Below 2 SD or 3rd percentile
• These should not be rigidly used! Consider premorbid level, sensitivity of tests etc.
• Major and Mild exist on a continuum
![Page 22: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/22.jpg)
Cognitive domains specified
DSM-5: • Complex attention • Executive function • Learning & memory • Language • Perceptual-motor • Social cognition
DSM-IV: • Memory impairment • Aphasia • Apraxia • Agnosia • Executive dysfunction
![Page 23: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/23.jpg)
Other Descriptors
• Possible vs Probable • Behavioral Disturbance:
– With: e.g. psychosis, mood, agitation – Without (not clinically significant)
• Severity (level of disability) – Mild: Instrumental ADL’s are preserved – Moderate: Basic ADL’s affected – Severe: Fully dependent
![Page 24: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/24.jpg)
Types of Neurocognitive Disorders
• Delirium • Major and Mild Neurocognitive
Disorder (NCD)
![Page 25: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/25.jpg)
Major and Mild Neurocognitive Disorder (NCD)
NCD due to: Alzheimer’s disease Vascular disease Traumatic Brain Injury Lewy body disease (several others) Other NCDs
![Page 26: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/26.jpg)
Neurocognitive Disorders of the DSM-5
![Page 27: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/27.jpg)
Neurocognitive Disorders of the DSM-5
Delirium
Traumatic Brain Injury
Maya Yutsis, PhD Clinical Neuropsychologist
Polytrauma Transitional Rehabilitation Program VA Palo Alto Health Care System
![Page 28: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/28.jpg)
Delirium
![Page 29: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/29.jpg)
Differential Diagnosis of Delirium
• Major Neurocognitive Disorder • Delirium due to a General Medical
Condition • Substance Intoxication Delirium • Substance Withdrawal Delirium • Delirium due to Multiple Etiologies • Delirium NOS
![Page 30: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/30.jpg)
Delirium Differs from other NCD
• Rapid Onset in hours to days • Linked to Medical Condition,
Substance Intoxication/Withdrawal, Medications, other causes
• May resolve completely • Symptom length:
– Acute- hours to days – Persistent-weeks to months
![Page 31: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/31.jpg)
Delirium Diagnostic Criteria • Key Features: Rapid and Abrupt onset of:
– Impaired Attention – Lack of Awareness of environment
• Change in at least ONE Cognitive Domain: – Recent Memory – Orientation – Language (i.e. rambled speech, mumbling, difficult to
understand) – Perceptual Disturbance
• Associated Features – Change in sleep-wake cycle – Change in emotional states – Worsening of behavioral problems in the evening
![Page 32: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/32.jpg)
NCD due to Traumatic Brain Injury
![Page 33: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/33.jpg)
Mild NCD due to TBI • Mild NCD
– Cognition: 3-16 %ile – Functional Independence: Mild decline but not impaired*
• Onset: Medically documented history of TBI (at least 1 of the criteria): – Loss of consciousness – Post-traumatic amnesia – Confused and disoriented immediately after the event – Neurological/Neuroimaging evidence, not required
• Symptom Course – Immediate onset following TBI or after recovering consciousness – Persist past acute post-injury periord – Any cognitive domain involvement – Recovery Trajectory: partial or complete – Weeks to months
*may need assistance but not fully dependent on others
![Page 34: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/34.jpg)
Major NCD due to TBI • Major NCD
– Cognition: <3%ile – Functional Independence: Impaired
• Onset: Medically documented history of TBI (at least 1 of the criteria): – Loss of consciousness – Post-traumatic amnesia – Confused and disoriented immediately after the event – Neurological/Neuroimaging evidence, IS required
• Symptom Course – Immediate onset following TBI or after recovering consciousness – Persist past acute post-injury periord – Any cognitive domain involvement – Recovery Trajectory: partial or complete – Weeks to months
![Page 35: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/35.jpg)
Neurocognitive Disorders of the DSM-5
NCD Associated with Lewy Body Disease
Allyson Rosen, PhD, ABPP-Cn
![Page 36: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/36.jpg)
NCD due to LBD • NCD • Onset: Insidious • Core symptoms
– Fluctuating cognition/attention/alertness – Visual hallucinations-well formed and detailed – Parkinsonian movement develops 1 year
AFTER cognitive impairment • Suggestive features
– Rapid eye movement (REM) sleep disorder – Neuroleptic sensitivity
![Page 37: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/37.jpg)
Key Issues in NCD due to LBD • Neuroleptic Sensitivity
– Worsening of movement disorder and impaired consciousness
• Onset: – Major NCD BEFORE motor (vs. Parkinson’s)
• Probable/Possible – Differ in number of core and suggestive
features • Fluctuations: Existing measures
– e.g. Ferman et al., 2004; Walker et al., 2000
![Page 38: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/38.jpg)
Beyond DSM 5
• McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12), 1863-1872.
![Page 39: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/39.jpg)
Neurocognitive Disorders of the DSM-5:
Alzheimer’s Disease
Brian Yochim, PhD, ABPP Clinical Neuropsychologist
Mental Illness Research, Education, and Clinical Center (MIRECC) VA Palo Alto Health Care System
Clinical Assistant Professor (Affiliated) Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
![Page 40: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/40.jpg)
Major or Mild NCD due to Alzheimer’s disease (AD)
• Insidious onset & gradual progression
• Major NCD: 2 or more cognitive domains impaired (unlike other Major NCDs) + impaired IADLs
• Mild NCD: 1 or more cognitive domains impaired, IADLs intact
![Page 41: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/41.jpg)
“Probable” vs. “Possible”: AD genetic mutation
• “Probable” vs. “Possible” are differentiated in part by presence of Alzheimer’s disease gene.
• This can be from family history or formal genetic testing.
![Page 42: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/42.jpg)
Major NCD due to AD
• Probable AD: either one must be present:
• Evidence of AD genetic mutation, or • All 3 of the following:
– Impairment in memory + 1 other domain – Progressive, gradual decline – No other possible etiology
• Otherwise, Possible AD is diagnosed
![Page 43: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/43.jpg)
Mild NCD due to AD
• Probable AD: requires evidence of Alzheimer’s gene.
• Possible AD: no evidence of AD gene, but all 3 of these factors exist: – Decline in memory & learning – Progressive, gradual decline – No evidence of other etiologies.
![Page 44: Neurocognitive Disorders of the DSM-5 - Stanford Medicinesgec.stanford.edu/.../1_DiagnosisRosenDSM5NCD_AR4.pdf · Neurocognitive Disorders of the DSM-5 Allyson Rosen, PhD, ABPP-Cn](https://reader034.vdocuments.us/reader034/viewer/2022052319/5abce54e7f8b9a321b8e95d7/html5/thumbnails/44.jpg)
Beyond DSM 5: MCI Reference